← Back to Patent Explorer
EP0123291A2 Expired / Lapsed EP ⏱️ 0.0 years remaining

Method for stabilizing interferon

Assignee: KH Neochem Co Ltd
•
Filing: 1984-04-19
•
Granted: —
•
Expires: 2004-04-19
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A method for stabilizing interferon which involves the addition of an alkali metal salt or magnesium chloride to interferon as a stabilizer. The stability of the interferon may be further enhanced by the addition of serum albumin and by freeze-drying. Also, a method for stabilizing interferon which comprises bringing interferon into contact with a saccharide that is selected from the group consisting of dextran, chondroitin sulfuric acid, starch, glycogen, inulin, dextrin and alginic acid salt.

Inventors

  • 👤 Yasuki Kato
  • 👤 Rie Ohshima
  • 👤 Naoko Tanaka
  • 👤 Eiji Hayakawa
  • 👤 Masuo Moriyama
  • 👤 Akira Kondo

Bibliographic Details

Application Number —
Jurisdiction EP
Data Source google_patents
Last Synchronized 2026-10-29 09:08
CPC Classifications
A; A61; A61K; A61K38/00; A61K38/16; A61K38/17; A61K38/19; A61K38/21; A61K38/215; A61K47/00; A61K47/02; A61K47/30; A61K47/36; A61K47/42

Claims Analysis

Total Claims: 16
Claim 1
Independent Claim 44 words
A method for stabilizing interferon which comprises bringing an interferon into contact with a stabilizing agent containing an alkali metal salt, magnesium chloride or a saccharide selected from the group consisting of dextran, chondroitin sulfuric acid, starch, glycogen, inulin, dextrin and alginic acid salt.
Claim 2
Independent Claim 44 words
A method for stabilizing interferon which comprises bringing an interferon into contact with a stabilizing agent containing an alkali metal salt, magnesium chloride or a saccharide selected from the group consisting of dextran, chondroitin sulfuric acid, starch, glycogen, inulin, dextrin and alginic acid salt.
Claim 3
Dependent Claim 19 words
The method according to claim 2, wherein the stabilizing agent is a serum albumin and an alkali metal salt.
Claim 4
Dependent Claim 22 words
The method according to claim 1 wherein the stabilizing agent is a saccharide defined in claim 1 and an alkali metal salt.
Claim 5
Dependent Claim 28 words
The method according to claim 1, 2 or 3, wherein the alkali metal salt is selected from the group consisting of sodium chloride, potassium chloride and lithium chloride.
Claim 6
Dependent Claim 22 words
The method according to claim 1, wherein the interferon is selected from the group consisting of Interferon- , Interferon- and Interferon- .
Claim 7
Dependent Claim 33 words
The method according to claim 1, wherein the amount of the alkali metal salt admixed with the interferon is 1 x 10 -11 - 3 x 10 -10 mole per unit of interferon.
Claim 8
Dependent Claim 30 words
The method according to claim 1, wherein the amount of saccharide admixed with the interferon is 5 x 10 -14 - 4 x 10 -12 mole per unit of interferon.
Claim 9
Dependent Claim 36 words
A composition which contains an interferon and a stabilizing agent containing alkali metal salt, magnesium chloride or saccharide selected from the group consisting of dextran, chondroitin sulfuric acid, starch, glycogen, inulin, dextrin and alginic acid salt.
Claim 10
Dependent Claim 36 words
A composition which contains an interferon and a stabilizing agent containing alkali metal salt, magnesium chloride or saccharide selected from the group consisting of dextran, chondroitin sulfuric acid, starch, glycogen, inulin, dextrin and alginic acid salt.
Claim 11
Dependent Claim 19 words
The composition according to claim 8, wherein the stabilizing agent is a serum albumin and an alkali metal salt.
Claim 12
Dependent Claim 22 words
The composition according to claim 8, wherein the stabilizing agent is a saccharide defined in claim 8 and an alkali metal salt.
Claim 13
Dependent Claim 28 words
The composition according to claim 8, 9 or 10, wherein the alkali metal salt is selected from the group consisting of sodium chloride, potassium chloride and lithium chloride.
Claim 14
Dependent Claim 22 words
The composition according to claim 8, wherein the interferon is selected from the group consisting of Interferon- , Interferon- and Interferon- .
Claim 15
Dependent Claim 33 words
The composition according to claim 8, wherein the amount of the alkali metal salt admixed with the interferon is 1 x 10 -11 - 3 x 10 -10 mole per unit of interferon.
Claim 16
Dependent Claim 29 words
The composition according to claim 8, wherein the amount of saccharide admixed with the interferon is 5 x 10 -14 - 4 x 10-12 mole per unit of interferon.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Maintenance schedule is calculated for granted US utility patents.

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag